Literature DB >> 7475717

Pneumocystis carinii pneumonia in Zimbabwe.

A S Malin1, L K Gwanzura, S Klein, V J Robertson, P Musvaire, P R Mason.   

Abstract

Pneumocystis carinii pneumonia (PCP) is said to be rare in Africa, with reported rates of 0-22% in human-immunodeficiency-virus (HIV) infected individuals with respiratory symptoms. Over one year in a central hospital in southern Africa, 64 HIV-infected patients with acute diffuse pneumonia unresponsive to penicillin and sputum smear-negative for acid-fast bacilli underwent fibreoptic bronchoscopy. Bronchoalveolar lavage fluid was assessed for bacteria, fungi, Pneumocystis carinii, and mycobacteria. 21 patients (33%) had PCP and 24 (39%) had tuberculosis; 6 of these had both infections. 5 patients had Kaposi's sarcoma (KS) associated with PCP, tuberculosis, or another infection, in 1 patient KS was the only finding, and in 21 no pathogen was identified. A logistic regression model was used to assess clinical, radiographic, and arterial blood gas predictors of PCP and tuberculosis. Fine reticulonodular shadowing on the chest radiograph (nodular component < 1 mm) was the strongest independent predictor of PCP (odds ratio 8.5 [95% CI 6.1-10.9]). A respiratory rate of more than 40/min was the best clinical predictor of PCP (odds ratio 11.2 [95% CI 8.8-13.6]). Median CD4+ T cell count for all cases of PCP was 134/microL (range 5-355) and for tuberculosis without PCP 206/microL (range 61-787). In resource-limited countries, a regionally appropriate management algorithm is required.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Infections; Respiratory Infections; Viral Diseases; Zimbabwe

Mesh:

Substances:

Year:  1995        PMID: 7475717     DOI: 10.1016/s0140-6736(95)91862-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  HIV Treatment in Developing Countries.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Authors:  Robert F Miller; Austin R Lindley; Helen E Ambrose; Adam S Malin; Ann E Wakefield
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

3.  High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.

Authors:  Leigh Dini; Mignon du Plessis; John Frean; Victor Fernandez
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

4.  Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi.

Authors:  Thomas K Hartung; Daniel Chimbayo; Joep J G van Oosterhout; Tarsizio Chikaonda; Gerard J J van Doornum; Eric C J Claas; Willem J G Melchers; Malcolm E Molyneux; Ed E Zijlstra
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

5.  Eosinophils Contribute to Early Clearance of Pneumocystis murina Infection.

Authors:  Taylor Eddens; Waleed Elsegeiny; Michael P Nelson; William Horne; Brian T Campfield; Chad Steele; Jay K Kolls
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

Review 6.  An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

Review 7.  Pathological and protective immunity to Pneumocystis infection.

Authors:  Taylor Eddens; Jay K Kolls
Journal:  Semin Immunopathol       Date:  2014-11-25       Impact factor: 9.623

8.  Causes of early mortality in HIV-infected TB suspects in an East African referral hospital.

Authors:  Rachel Kyeyune; Saskia den Boon; Adithya Cattamanchi; J Lucian Davis; William Worodria; Samuel D Yoo; Laurence Huang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

9.  Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi.

Authors:  David K Lewis; Maria Callaghan; Kamija Phiri; James Chipwete; James G Kublin; Eric Borgstein; Ed E Zijlstra
Journal:  Malawi Med J       Date:  2002-09       Impact factor: 0.875

10.  Molecular detection of pneumocystis jirovecii in patients with respiratory tract infections.

Authors:  Oyebode Armstrong Terry Alli; David Olusoga Ogbolu; Olufunmi Ademola; Musiliu Adewale Oyenike
Journal:  N Am J Med Sci       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.